• Zum Hauptinhalt springen
  • Zum Footer springen
  • Deutsch - de
  • English - en

    Comprehensiv...

    • Clinical research
      • Interdisciplinary pediatric study center (Hauner iPSC)
      • Michael Albert
      • Scivias Study
      • TRACE Study
      • LEOPARD Study
      • Hematology/Oncology/Coagulation
    • Research Labs
      • Binder Lab
      • Bohlen Lab
      • Gaertner Lab
      • Griese Lab
      • Hauck Lab
      • Hübner Lab
      • Jeremias lab
      • Kim-Hellmuth Lab
      • Klein Lab
      • Koletzko Lab
      • Kotlarz Lab
      • Lange-Sperandio Lab
      • Nußbaum Lab
      • Rosenecker Lab
      • Schaub Lab
      • Schmid Lab
      • Schwerd Lab
    • PhD Program
    • Technology platforms
      • Bioinformatics
      • Flow Cytometry
      • High throughput sequencing
      • Microscopy
      • Mass spectrometry
      • Hauner Biobank
      • Organoid Lab
      • Humangenetik am Hauner
    • News/Events
      • News
      • Rare Disease Day
      • ECHO-Meeting
      • Meinhard von Pfaundler-Lectures
      • Klaus Betke Symposium
    • Join us!
    1. CCRC-HaunerEN
    2. Research Labs
    3. Gaertner Lab

    Gaertner Lab

    Emmy-Noether Research Group

    Clinical research group assessing lung physiology and optimizing clinical care of newborn infants

    PI: Vincent Gaertner

    Research topics

    • Understanding the physiology of fetal-to-neonatal transition
    • Advancing clinical knowledge on neonatal resuscitation and stabilization after birth
    • Illuminating (patho-)physiology of different ventilation techniques in preterm infants
    • Supporting clinical decision-making by performing randomized clinical trials and systematic meta-analyses

    Contact

    Vincent D. Gaertner, MD BSc

    Principal Investigator

    Lindwurmstr. 4
    80337 Munich
    089-4400-57783
    qluJyiubexgSipbuipvim äv:femi
    Greta Fetscher
    Doctoral student
    xpibg-wibcyzi:pygvnöfc ävfemi
    more on the person
    Dr. Bärbel Maag
    Clinician Scientist
    jgWipjiä/Svggxvimsful+vfiuyziu/mi
    Carlotta Ostner
    Doctoral student
    nyWS-ücbuipygWvöfcsävf mi
    more on the person
    Susanne Reinfeld
    Clinician Scientist
    cfcguui piluwiämvimsfulGvfiuyziu-mi
    Katharina Stöckemann
    Clinician Scientist
    ogbzngplugecbüiyoivguuvimefulhvfiuyziuemi
    Maria Wall
    Doctoral Student
    v égDääygvöfc ävfemi
    Alexia Zanghi
    Doctoral student
    gäiƒlag ßguxzlbfv/mi
    Vera Zuech
    Doctoral student
    Jqipg-ßfiyzayWgvöfJc ävf mi

    Fields of research

    The day we are born is the single most dangerous day in our life with the highest mortality rate. Accordingly, birth asphyxia and its complications are the most important factor for childhood mortality worldwide. This is due to the complex transition the lung needs to undergo within seconds after birth: Before birth, the lung is liquid-filled and oxygenation occurs via the placenta. After birth, the infant needs to start crying to aerate the lung. We are committed to unraveling the detailed pulmonary mechanisms of this unique moment in life. To do this, we collect various physiological data in human infants immediately after birth, starting with the first breath to better understand initial lung aeration and pulmonary perfusion. This will help us improve neonatal respiratory management during the transitional period.

    Approximately 5-10% of newborn infants require some form of assistance in order to transition from a liquid-filled lung to an air-filled lung which is the prerequisite to successfully initiate oxygenation and ventilation. Failure to aerate the lung necessitates additional support using stimulation, respiratory support and in few selected cases, cardiopulmonary resuscitation. Due to the emergency nature of the situation, there are still many open questions with regard to the initial management of term and preterm infants immediately after birth. Our research group is dedicated to improving newborn health by critically appraising the steps in the neonatal resuscitation algorithm and by rigorously evaluating possibilities to improve the cardiorespiratory management. This includes observational studies as well as clinical trials which will allow improvement in immediate clinical management in the future.

    Very preterm infants have a low lung compliance but a high chest wall compliance making them prone to (micro-)injuries. Accordingly, almost all very preterm infants require some form of (ideally non-invasive) respiratory support. The mode and settings of this respiratory support and the timing and modalities of additional medical management (caffeine, surfactant, etc) are based on current guidelines but there are still many unanswered questions in terms of respiratory management of the most vulnerable population. Thus, there is still a large need for patient-centered outcome-driven trials to improve respiratory management. Also, (patho-)physiology of different ventilation techniques as well as during various interventions needs to be understood better in order to improve patient outcomes. Accordingly, physiological studies in human infants are needed in order to tease out the ideal management in an individualized manner.

    Clinical decision-making should always be supported by the best available clinical data. We are committed to translating pre-clinical data as well as clinical data from observational studies to randomized clinical trials in order to implement novel ideas into clinical practice. Currently, we are evaluating the effect of a higher vs lower pressure immediately after birth in very preterm infants in a multicenter, randomized controlled trial (LEOPARD trial, see below). Also, we are combining data from RCTs into systematic reviews by collaboration with the Cochrane Library.

    Current projects

    The LEOPARD trial is a large, multi-center, international randomized controlled trial initiated by this research group comparing a high (10-12 cmH2O) vs low (5-7 cmH2O) positive end-expiratory pressure during the first ten minutes after birth in very preterm infants (24 0/7 to 31 6/7 weeks gestational age at birth). As a pragmatic trial, all other interventions are at the discretion of the treating clinical team. Primary outcome is a clinically important DOOR outcome at 36 weeks corrected postmenstrual age including death, moderate/severe bronchopulmonary dysplasia, severe brain lesions, long-term mechanical ventilation, pneumothoraces and respiratory failure. The study will be conducted in several centres in Germany, Switzerland and Australia.

    More on the LEOPARD trial

    The EAGLE study is a prospective observational study assessing electrical impedance tomography (EIT) of healthy term infants after vaginal delivery. In this study, EIT recordings will be performed immediately after birth and starting before the first breath in order to understand changes in lung aeration and pulmonary perfusion in healthy infants which will increase our understanding of this crucial moment in life.

    Current status: manuscript publishes

    The ALBATROSS study is a prospective observational study in late preterm and term infants assessing EIT data immediately after birth after cesarean section in order to decipher intrapulmonary volume changes in infants with respiratory distress and compare them to infants without respiratory distress.

    Current status: manuscript published

    The RAVEN study is an observational study in healthy term infants after birth assessing electrical impedance tomography (EIT) recordings to describe differences between infants born vaginally and infants born via cesarean section.

    Current status: manuscript submitted

    The LION study is a prospective observational study in preterm infants undergoing surfactant application. In this study, we aim to assess electrical impedance tomography (EIT) recordings during intratracheal surfactant application in order to assess lung volume changes during distinct manipulations such as laryngoscopy, surfactant instillation, etc

    Current status: recruitment ongoing

    The RELAX study is a prospective randomized crossover study in preterm infants < 32 weeks gestational age and 3-14 days of age who are still on supplemental oxygen. Infants will receive an intervention period (recurrent recruitment maneuvers up to 4 cmH2O) and a control period (no changes to the ventilator) for two hours each. Primary outcome is the change in end-expiratory lung impedance (EELI) as measured by electrical impedance tomography.

    Current status: recruitment ongoing

    The COAT review is a systematic review with meta-analysis in conjunction with the Cochrane collaboration where we critically appraise the evidence on air versus additional oxygen supplementation in term infants needing resuscitation immediately after birth

    Current status: manuscript submitted

    PANDA study: recruitment ongoing

    EPSILON study: recruitment finished

    PHOENIX study: recruitment finished

    INSTANT study: recruitment finished

    CHOP study: analysis phase

    AFRO study: recruitment phase

    DOOR studies: analysis phase

    ELEPHANT review: published

    MRSOPA review: published

    INSPIRE 2.0 study: protocol phase

    Sync_HFO study: protocol phase

    Selected publications

    1. Gaertner VD, Ramin-Wright L, Waldmann AD, Belting C, Gähwiler K, Büchler VL, Haslinger C, Bassler D & Rüegger CM (2026). The first breaths after birth—early lung function in healthy term infants. American Journal of Respiratory and Critical Care Medicine
    2. Gaertner VD, Büchler VL, Waldmann AD, Bassler D, & Rüegger CM (2024). Deciphering Mechanisms of Respiratory Fetal-to-Neonatal Transition in Very Preterm Infants. American Journal of Respiratory and Critical Care Medicine
    3. Gaertner VD, Waldmann AD, Davis PG, Bassler D, Springer L, Thomson J, Tingay DG, & Rüegger CM (2021). Transmission of oscillatory volumes into the preterm lung during noninvasive high-frequency ventilation. American Journal of Respiratory and Critical Care Medicine
    4. Rüegger CM, Dawson JA, Cracknell J, Fiander M, Davis PG, & Gaertner VD (2024). Air versus supplemental oxygen for resuscitation of term or late preterm infants at birth. Cochrane Database for Systematic Reviews
    5. Gaertner VD, Waldmann AD, Tingay DG & Rüegger CM (2026). Non-invasive Imaging of the Neonatal Lung Using Electrical Impedance Tomography: A Narrative Review. Annals of the ATS
    6. Belting C, Ramin-Wright L, Kraus A, Waldmann AD, Bassler D, Büchler VL, Gähwiler K, Rüegger CM & Gaertner VD (2026). Early Postnatal Respiratory Dynamics in Term and Late Preterm Infants with Respiratory Distress. Archives of Disease in Childhood: Fetal & Neonatal Edition
    7. Gaertner VD, Minocchieri S, Waldmann A, Mühlbacher T, Bassler D, & Rüegger CM for the SUNSET study group (2022). Prophylactic surfactant nebulisation for the early aeration of the preterm lung: a randomised clinical trial. Archives of Disease in Childhood: Fetal and Neonatal Edition
    8. Gaertner VD, Thomann J, Bassler D, Rüegger C (2021). Surfactant nebulization to prevent intubation in preterm infants: A systematic review and meta-analysis. Pediatrics
    9. Gaertner VD, Waldmann AD, Davis PG, Bassler D, Springer L, Tingay DG, & Rüegger CM (2022). Lung volume changes during apnoeas in preterm infants. Archives of Disease in Childhood: Fetal and Neonatal Edition
    10. Gaertner VD, Waldmann AD, Davis PG, Bassler D, Springer L, Tingay DG, & Rüegger CM (2022). Lung volume distribution in preterm infants on non-invasive high-frequency ventilation. Archives of Disease in Childhood: Fetal and Neonatal Edition
    11. Gaertner VD, Rüegger CM, Bassler D, O'Currain E, Kamlin COF, Hooper S, Davis PG, & Springer L (2021). Effects of tactile stimulation on spontaneous breathing during face mask ventilation. Archives of Disease in Childhood: Fetal and Neonatal Edition
    12. Gaertner VD, Rüegger CM, O’Currain E, Kamlin COF, Hooper S, Davis PG, & Springer L (2020). Physiological responses to facemask application in newborns immediately after birth. Archives of Disease in Childhood: Fetal and Neonatal Edition
    13. Belting C, Rüegger CM, Waldmann AD, Bassler D, & Gaertner VD (2024). Rescue nasopharyngeal tube for preterm infants non-responsive to initial ventilation after birth. Pediatric Research
    14. Gaertner VD & Rüegger CM (2023). Optimising success of neonatal extubation: respiratory support. Seminars in Fetal and Neonatal Medicine
    15. Gaertner VD, Helwig ED, Manley BJ, Kamlin COF, Kraus A, & Rüegger CM (2022). “Harry Potter and the Multitudinous Maladies” – Evaluation of morbidity and mortality among witches and wizards: A Retrospective Population-Based Observational Study. Medical Journal of Australia
    16. Gaertner VD, Mühlbacher T, Waldmann AD, Bassler D, & Rüegger CM (2023). Early prediction of pulmonary outcomes in preterm infants using electrical impedance tomography. Frontiers in Pediatrics
    17. Mutesu-Kapembwa K, Lakhwani J, Benkele RG, Machona S, Shamalavu MS, Chintende JM, Chisela SM, Kapoma S, Mwanza J, Chelu W, Mwendafilumba M, Kapembwa K, & Gaertner VD (2022). Bridging the gap in neonatal resuscitation in Zambia. Frontiers in Pediatrics
    18. Gaertner VD, Restin T, Bassler D, Fauchère JC, & Rüegger CM (2022). Case Report: Intrapulmonary Tidal Volumes in a Preterm Infant with Chest Wall Rigidity. Frontiers in Pediatrics
    19. Gaertner VD, Waldmann AD, Bassler D, Hooper S, & Rüegger CM (2022). Intrapulmonary Volume Changes during Hiccups versus Spontaneous Breaths in a Preterm Infant. Neonatology
    20. Gaertner VD, Bassler D, Zimmermann R, & Fontijn J (2021). Reference values for umbilical artery lactate by mode of delivery and gestational age – a retrospective observational study. Neonatology
    21. Gaertner VD, Bassler D, Rüegger CM (2021). Does surfactant nebulization prevent early intubation in preterm infants? A protocol for a systematic review and meta-analysis. Systematic Reviews
    22. Gaertner VD, Rüegger CM, Wagner M, Mileder L, Dvorsky R, Springer L & Kaufmann M (2026). Corrective steps during neonatal mask ventilation – a narrative review of the evidence behind the MR SOPA acronym. Resuscitation Plus
    23. Plastina L*, Gaertner VD*, Waldmann A, Thomann J, Bassler D, & Rüegger CM (2021). The DELUX study – Development of Lung volumes during extubation of preterm infants. Pediatric Research
    24. Büchler V, Gaertner VD, Thomann J, Bassler D, & Rüegger CM (2024). Lung volume changes in stable preterm infants weaned from nCPAP to high-flow: a prospective cohort study. CHEST Pulmonary
    25. Mileder L, Wagner M, Kaufmann M, Gaertner VD, Rüegger CM, & Springer L (2023). How should we perform neonatal mask ventilation during MR SOPA corrective steps? Resuscitation Plus
    26. Thomann J, Rüegger CM, Gaertner VD, O'Currain E, Kamlin COF, Davis PG, & Springer L (2022). Tidal volumes during delivery room stabilization of (near) term infants. BMC Pediatrics
    27. Thomann J, Gaertner VD, Waldmann AD, Plastina L, Bassler D, & Rüegger CM (2023). Nasal high frequency oscillatory highflow therapy in preterm infants: A randomized crossover trial. Pediatric Pulmonology


    Full list of publications

    October 2025

    David Tingay joins the research group

    Prof. David Tingay is a clinical researcher from the Murdoch Children's Research Institute as well as a consultant neonatologist at the Royal Children's Hospital in Melbourne, Australia. He is one of the leading researchers in neonatal respiratory physiology and joins the research group for two months during his sabbatical. Welcome, David!

    February 2025

    Vincent Gaertner funded by the German Research Foundation (DFG)

    The research project “From EAGLE to LEOPARD” by DZL researcher Vincent Gaertner, doctor at the Dr. von Hauner Children's Hospital (LMU) and principal investigator at the DZL Munich site (CPC-M), is funded by the German Research Foundation (DFG) as an Emmy Noether Research Group over a period of six years: Dr Gaertner wants to improve our understanding how this transition works and how premature babies can be optimally supported in the delivery room. The aim is to improve medical care in this unique and critical phase of life, thereby increasing the chances of survival and the later quality of life of newborns.

    Read full text at DZL website


    November 2024

    Vincent Gaertner is awarded the Future-of-Paediatric-Care Grant and the Early Career Investigator Prize by the European Society for Paediatric Research


    September 2024

    Vincent Gaertner receives the Adalbert-Czerny-Medal of the German Society for Pediatric and Adolescent Medicine

    ​​Vincent Gaertner, MD (35) was awarded with the Adalbert-Czerny-Medal 2024 by the German Society for Pediatric and Adolescent Medicine. The prize, which comprises 10'000 euro and a medal of Adalbert Czerny, rewards particularly important scientific achievements in the field of pediatrics.

    Read full text here

    Watch interview

    Funding

    This research group is funded by various public agencies including the German Research Foundation via the Emmy-Noether-Programme, the European Society for Paediatric Research, the LMU Hospital, the Friedrich-Baur-Stiftung and the German Center for Lung Research.

    Collaborations

    We are collaborating closely with our partners in University Hospitals and Universities from the entire world, from San Diego, California, via several European sites, Lusaka in Zambia down to Melbourne, Australia. Together with our partners, we develop important clinical trials, have trainee partnerships to improve learning from our students and organize various annual meetings.

    Open positions:

    We are actively looking for researchers at all levels (postdocs, clinician scientists, PhD and MD students, interns, study nurses). We offer an excellent research atmosphere in a clinical research group and we are looking for highly motivated individuals who

    • Are interested in neonatal care and/or lung physiology
    • Want to work in a research atmosphere where clinically important questions are answered
    • Want to see their research output translated into clinical care immediately
    • Enjoy working in a collaborative team surrounded by a vibrant scientific environment


      Our group is dedicated to better understand the physiology of cardiopulmonary adaptation during fetal-to-neonatal transition and to optimize clinical respiratory care for both term and preterm infants. We perform large and small clinical trials with clinically pressing questions, translate findings into cutting-edge systematic reviews supporting international clinical guidelines, and try to understand lung pathophysiology during clinical interventions. To do this, we collaborate with a wide scientific network in Munich, Germany and worldwide.


      Please do not hesitate to get in touch via email if you are interested in working with us or if you want to discuss collaboration projects.

      Research at CCRC Hauner

      Contact LMU Klinikum

      Contact CCRC Hauner

      Haunersches

      CCRC Hauner - Comprehensive Childhood Research Center

      Kinderklinik und Kinderpoliklinik

      im Dr. von Haunerschen Kinderspital

      Ludwig Maximilians Universität München

      Lindwurmstr. 4

      80337 Munich, Germany


      Editor login
      Imprint | Data-Safety | Accessibility